Johnson & Johnson antiviral pill for dengue shows early efficacy
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we see data from ESMO showing that Roche's…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today, we see data from ESMO showing that Roche’s alectinib works well in some early stage lung cancers, see our first preventative dengue pill, and more.
What's Your Reaction?
